How do I buy Novavax (NVAX) stock?

Buying Novavax (NVAX) stock is now easy and instant through the Gotrade app. Download the Gotrade app from the App Store or Google Play. Create an account and verify your identity. Make a deposit. Search for the code "NVAX", then tap "Trade". Tap the "Buy" button. Enter the amount you want to buy. You have two options: Buy NVAX by number of shares. Buy fractional shares in dollars, starting from $1. Swipe up to confirm your order, and you're done!

How do I tell if NVAX is expensive or cheap?

There's no single perfect answer, but common approaches include: Compare valuation (e.g., P/E, P/S) against historical averages or competitors. Review revenue and earnings growth. Check margins and cash flow. Evaluate business outlook and the company's position within its industry. You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Novavax (NVAX) Stock

Q: What is the minimum investment for NVAX on Gotrade?

On Gotrade , you don't have to buy a full share. With fractional shares, you can start investing in Novavax from just $1. A small budget shouldn't stop you from building a US stock portfolio.

NASDAQ · NVAX

Trade NVAX

Key stats

Market cap: $1.65B
Price / Earnings ratio: -21.9x
EPS (TTM): -$0.46
Volume: Loading
52-week high: $13.39
52-week low: $6.20
EPS vs analyst estimate: +50.0%Q3 FY25 · -$0.48 vs -$0.96

Source: third-party data provider, as of November 13, 2026

EPS estimate: analyst consensus

Compare with NVAX

Technical indicators

RSI 14: 46.20
MACD 12/26/9: -0.15
EMA 9 of MACD: -0.13
MACD histogram: -0.02
SMA 50: $10.60; Price below SMA 50
EMA 50: $10.33; Price below EMA 50
SMA 200: $9.34; Price above SMA 200
EMA 200: $9.34; Price above EMA 200

Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.

Analyst ratings

Analyst consensus: Sell

Based on 2 analyst ratings

Strong Sell1

Sell0

Hold0

Buy1

Strong Buy0

Third-party analyst opinion, not a recommendation from Gotrade.

Financials

Performance

Revenue

Net income

Net margin %

2021

2022

2023

2024

2025

2B2B785M0

Debt & Balance Sheet

Total assets

Total liabilities

2021

2022

2023

2024

2025

4B2B1B0

Revenue to Profit

2025

$1.1B

Revenue

$0.0

Cost of revenue

$1.1B

Gross profit

$0.0

Operating expenses

$440.3M

Net income

Earnings

EPS forecast

Actual EPS

$-0.48

$-0.96

Q3FY25

$-0.56

Q4FY25

$-0.14

Q1FY26

$-0.26

Q2FY26

$-0.15

Q3FY26

The market is expecting earnings per share of -$0.15 for this quarter. The company has not yet shared when it is announcing earnings.

Source: third-party data provider

About Novavax

Novavax, Inc. is a biotechnology company that promotes improved health globally through the discovery, development and commercialization of innovative vaccines to prevent serious infectious diseases. The company's proprietary recombinant technology platform combines the power and speed of genetic engineering to efficiently produce highly immunogenic nanoparticles designed to address urgent global health needs.

SectorHealthcare

IndustryBiotechnology

Employees749

CEOMr. John Charles Jacobs M.B.A.

IPO DateDec 5, 1995

HeadquartersGaithersburg, MD

Key Executives

Name	Title	Year Born
Mr. John Charles Jacobs M.B.A.	President, CEO & Director	1967
Mr. James Patrick Kelly C.F.A.	Executive VP, CFO & Treasurer	1966
Mr. Richard P. Crowley	Executive VP & COO	1957
Mr. Mark J. Casey Esq., J.D.	Executive VP, Chief Legal Officer & Corporate Secretary	1963
Ms. Elaine O'Hara	Executive VP & Chief Strategy Officer	1968
Ms. Naina Zaman	Director of Investor Relations	—
Mr. Troy Morgan Esq., J.D.	Senior VP, Deputy General Counsel & Chief Compliance Officer	1971
Ms. Erika S. Trahan	Associate Director of Investor & Public Relations	—
Mr. Ian J. Watkins	Executive VP & Chief Human Resources Officer	1963
Ms. Silvia Taylor M.B.A.	Executive VP, Chief Corporate Affairs Officer & Head of Novavax Sweden	—

Seasonality

Monthly price change (%)

	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2021											+21.0	-25.7
2022	-34.4	-12.4	-12.0	-39.4	+2.9	-4.1	-4.6	-38.7	-43.0	+19.7	-25.0	-39.0
2023	+11.4	-17.5	+1.0	+3.6	+4.3	-3.8	+25.7	-8.6	-11.8	-6.1	-21.4	-13.8
2024	-20.5	+22.9	-11.3	-6.9	+221.8	-30.5	+0.6	-1.5	-0.3	-22.0	-6.7	-8.3
2025	+1.4	-1.2	-18.6	+11.2	+14.5	-10.9	+0.6	+13.9	+14.8	-11.6	-10.9	+0.4
2026	+24.1	+16.7	-19.5	-1.1	+36.4	-10.4	-22.6	+26.5	+6.8	-4.9	+4.7

Stocks in the same sector

Vertex Pharmaceuticals

ABEO

Abeona Therapeutics Inc.

FAQ

Buying Novavax (NVAX) stock is now easy and instant through the Gotrade app.

Download the Gotrade app from the App Store or Google Play.
Create an account and verify your identity.
Make a deposit.
Search for the code "NVAX", then tap "Trade".
Tap the "Buy" button.
Enter the amount you want to buy. You have two options:
1. Buy NVAX by number of shares.
2. Buy fractional shares in dollars, starting from $1.
Swipe up to confirm your order, and you're done!

On Gotrade, you don't have to buy a full share. With fractional shares, you can start investing in Novavax from just $1. A small budget shouldn't stop you from building a US stock portfolio.

At the moment, Novavax (NVAX) does not pay dividends because it focuses on reinvesting profits for company growth (a growth stock). However, you can still potentially earn profit from share price increases (capital gains). Track NVAX's performance via the price chart in the Gotrade app.

Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA).

You can place an order any time. It goes through when the US market (NYSE/NASDAQ) opens: 9:30 AM to 4:00 PM New York time, Monday to Friday. Pre-market and after-hours trading are open too.

The market is closed on US public holidays. The Gotrade app shows whether the market is open.

There's no single perfect answer, but common approaches include:

Compare valuation (e.g., P/E, P/S) against historical averages or competitors.
Review revenue and earnings growth.
Check margins and cash flow.
Evaluate business outlook and the company's position within its industry.

You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Trade Faster. Easier. Smarter.

#ReadyGoTrade

Welcome Reward up to $1,888

Create an account and trade US stocks on Gotrade

Download app

*Terms & conditions apply

Novavax (NVAX) Stock

Key stats

Compare with NVAX

Recent news

Novavax Raises FY26 Revenue Outlook By 50% – Retail Says Licensing Deals Could Create ‘Tremendous Financial Leverage’

Novavax Raises FY26 Revenue Outlook By 50% – Retail Says Licensing Deals Could Create ‘Tremendous Financial Leverage’

Novavax (NVAX) May Report Negative Earnings: Know the Trend Ahead of Q3 Release

Novavax (NVAX) May Report Negative Earnings: Know the Trend Ahead of Q3 Release

Moderna Jumps 4% Despite William Blair Downgrade on Valuation; Novavax and BioNTech Edge Higher

Moderna Jumps 4% Despite William Blair Downgrade on Valuation; Novavax and BioNTech Edge Higher